Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Humanized Agonistic Anti-CD28 Monoclonal Antibody

EU orphan designation number: EU/3/05/276   
Active ingredient: Humanized Agonistic Anti-CD28 Monoclonal Antibody
Indication: Treatment of B-cell Chronic Lymphocytic Leukaemia (B-CLL)
Sponsor: TeGenero AG
Science Park Wuerzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/04/2005 Orphan designation EMEA/OD/091/04 (2005)1205 of 11/04/2005